These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39154897)

  • 21. Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units.
    Oostdijk EA; Smits L; de Smet AM; Leverstein-van Hall MA; Kesecioglu J; Bonten MJ
    Intensive Care Med; 2013 Apr; 39(4):653-60. PubMed ID: 23203301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study.
    Feng JY; Peng CK; Sheu CC; Lin YC; Chan MC; Wang SH; Chen CM; Shen YC; Zheng ZR; Lin YT; Yang KY;
    Clin Microbiol Infect; 2021 Oct; 27(10):1465-1473. PubMed ID: 33540113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology.
    Marchenay P; Blasco G; Navellou JC; Leroy J; Cholley P; Talon D; Bertrand X; Gbaguidi-Haore H
    Med Mal Infect; 2015; 45(1-2):34-40. PubMed ID: 25640914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftazidime/avibactam combined with colistin: a novel attempt to treat carbapenem-resistant Gram-negative bacilli infection.
    Zheng Z; Shao Z; Lu L; Tang S; Shi K; Gong F; Liu J
    BMC Infect Dis; 2023 Oct; 23(1):709. PubMed ID: 37864200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy and nephrotoxicity of intravenous colistin sulfate in the treatment of carbapenem-resistant gram-negative bacterial infections: a retrospective cohort study.
    Jin J; Zhu J; Zhu Z; Kim WY; O'Rourke J; Lin Z; Chen M
    Ann Transl Med; 2022 Oct; 10(20):1137. PubMed ID: 36388829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world data on the effects of colistin sulfate and polymyxin B sulfate in the treatment of pneumonia induced by CR-GNB.
    Liu D; Jie F; Ding Y; Qu H; Chen D; Huang J
    J Infect Dev Ctries; 2024 Jul; 18(7):1050-1057. PubMed ID: 39078788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
    Cheng A; Chuang YC; Sun HY; Sheng WH; Yang CJ; Liao CH; Hsueh PR; Yang JL; Shen NJ; Wang JT; Hung CC; Chen YC; Chang SC
    Crit Care Med; 2015 Jun; 43(6):1194-204. PubMed ID: 25793437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality.
    Capone A; Giannella M; Fortini D; Giordano A; Meledandri M; Ballardini M; Venditti M; Bordi E; Capozzi D; Balice MP; Tarasi A; Parisi G; Lappa A; Carattoli A; Petrosillo N
    Clin Microbiol Infect; 2013 Jan; 19(1):E23-E30. PubMed ID: 23137235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
    Lai CC; Chen YS; Lee NY; Tang HJ; Lee SS; Lin CF; Lu PL; Wu JJ; Ko WC; Lee WS; Hsueh PR
    Infect Drug Resist; 2019; 12():627-640. PubMed ID: 30936726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections.
    Batirel A; Balkan II; Karabay O; Agalar C; Akalin S; Alici O; Alp E; Altay FA; Altin N; Arslan F; Aslan T; Bekiroglu N; Cesur S; Celik AD; Dogan M; Durdu B; Duygu F; Engin A; Engin DO; Gonen I; Guclu E; Guven T; Hatipoglu CA; Hosoglu S; Karahocagil MK; Kilic AU; Ormen B; Ozdemir D; Ozer S; Oztoprak N; Sezak N; Turhan V; Turker N; Yilmaz H
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1311-22. PubMed ID: 24532009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
    Paul M; Daikos GL; Durante-Mangoni E; Yahav D; Carmeli Y; Benattar YD; Skiada A; Andini R; Eliakim-Raz N; Nutman A; Zusman O; Antoniadou A; Pafundi PC; Adler A; Dickstein Y; Pavleas I; Zampino R; Daitch V; Bitterman R; Zayyad H; Koppel F; Levi I; Babich T; Friberg LE; Mouton JW; Theuretzbacher U; Leibovici L
    Lancet Infect Dis; 2018 Apr; 18(4):391-400. PubMed ID: 29456043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for acute kidney injury in critically ill patients with bacteraemia by carbapenem non-susceptible Gram negative bacteria.
    Papadimitriou-Olivgeris M; Assimakopoulos SF; Kolonitsiou F; Solomou A; Vamvakopoulou S; Spyropoulou A; Karamouzos V; Anastassiou ED; Papachristou E; Spiliopoulou I; Christofidou M; Fligou F; Marangos M
    Infez Med; 2019 Dec; 27(4):380-392. PubMed ID: 31846987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma.
    Ceccarelli G; Alessandri F; Moretti S; Borsetti A; Maggiorella MT; Fabris S; Russo A; Ruberto F; De Meo D; Ciccozzi M; Mastroianni CM; Venditti M; Pugliese F; d'Ettorre G
    Pathogens; 2022 Nov; 11(11):. PubMed ID: 36365046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ICU-CARB score: a novel clinical scoring system to predict carbapenem-resistant gram-negative bacteria carriage in critically ill patients upon ICU admission.
    Dai Y; Zhang L; Pan T; Shen Z; Meng T; Wu J; Gu F; Wang X; Tan R; Qu H
    Antimicrob Resist Infect Control; 2023 Oct; 12(1):118. PubMed ID: 37898771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colistin Resistance Among Multi-Drug Resistant Gram-Negative Bacterial Isolates From Different Clinical Samples of ICU Patients: Prevalence and Clinical Outcomes.
    Panigrahi K; Pathi BK; Poddar N; Sabat S; Pradhan S; Pattnaik D; Patro S; Praharaj AK
    Cureus; 2022 Aug; 14(8):e28317. PubMed ID: 36158344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective analysis of carbapenem-resistant
    Ferlicolak L; Altintas ND; Yoruk F
    J Intensive Med; 2024 Apr; 4(2):181-186. PubMed ID: 38681792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
    Shah PG; Shah SR
    J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors and outcome for colistin-resistant Acinetobacter nosocomialis bacteraemia in patients without previous colistin exposure.
    Wang YC; Lee YT; Yang YS; Chen CT; Chiu CH; Yin T; Kuo SC; Chen TL; Lin JC; Wang FD; Fung CP; Chang FY
    Clin Microbiol Infect; 2015 Aug; 21(8):758-64. PubMed ID: 25980356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
    Amat T; Gutiérrez-Pizarraya A; Machuca I; Gracia-Ahufinger I; Pérez-Nadales E; Torre-Giménez Á; Garnacho-Montero J; Cisneros JM; Torre-Cisneros J
    Clin Microbiol Infect; 2018 Jun; 24(6):630-634. PubMed ID: 28970161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients.
    Tsioutis C; Kritsotakis EI; Karageorgos SA; Stratakou S; Psarologakis C; Kokkini S; Gikas A
    Int J Antimicrob Agents; 2016 Nov; 48(5):492-497. PubMed ID: 27542315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.